1. A woman with episodic headaches, sweating, and palpitations. (29th June 2011) Authors: Jones, Angus; Bull, Matthew; Vaidya, Bijay Journal: BMJ Issue: Volume 342(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Associations between low HDL, sex and cardiovascular risk markers are substantially different in sub-Saharan Africa and the UK: analysis of four population studies. Issue 5 (20th May 2021) Authors: Greiner, Rosamund; Nyrienda, Moffat; Rodgers, Lauren; Asiki, Gershim; Banda, Louis; Shields, Beverly; Hattersley, Andrew; Crampin, Amelia; Newton, Robert; Jones, Angus Journal: BMJ global health Issue: Volume 6:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. Issue 11 (2nd November 2015) Authors: Shields, Beverley M; Peters, Jaime L; Cooper, Chris; Lowe, Jenny; Knight, Bridget A; Powell, Roy J; Jones, Angus; Hyde, Christopher J; Hattersley, Andrew T Journal: BMJ open Issue: Volume 5:Issue 11(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18–50 years. Issue 9 (26th September 2019) Authors: Lynam, Anita; McDonald, Timothy; Hill, Anita; Dennis, John; Oram, Richard; Pearson, Ewan; Weedon, Michael; Hattersley, Andrew; Owen, Katharine; Shields, Beverley; Jones, Angus Journal: BMJ open Issue: Volume 9:Issue 9(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. Issue 12 (21st December 2020) Authors: Angwin, Catherine; Jenkinson, Caroline; Jones, Angus; Jennison, Christopher; Henley, William; Farmer, Andrew; Sattar, Naveed; Holman, Rury R; Pearson, Ewan; Shields, Beverley; Hattersley, Andrew Journal: BMJ open Issue: Volume 10:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗